Cargando…

Cost Evaluation of Evidence-Based Treatments

Many treatment programs have adopted or are considering adopting evidence-based treatments (EBTs). When a program evaluates whether to adopt a new intervention, it must consider program objectives, operational goals, and costs. This article examines cost concepts, cost estimation, and use of cost in...

Descripción completa

Detalles Bibliográficos
Autores principales: Sindelar, Jody L., Ball, Samuel A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Institute on Drug Abuse 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120119/
https://www.ncbi.nlm.nih.gov/pubmed/22002453
_version_ 1782206617763184640
author Sindelar, Jody L.
Ball, Samuel A.
author_facet Sindelar, Jody L.
Ball, Samuel A.
author_sort Sindelar, Jody L.
collection PubMed
description Many treatment programs have adopted or are considering adopting evidence-based treatments (EBTs). When a program evaluates whether to adopt a new intervention, it must consider program objectives, operational goals, and costs. This article examines cost concepts, cost estimation, and use of cost information to make the final decision on whether to adopt an EBT. Cost categories, including variable and fixed, accounting and opportunity, and costs borne by patients and others, are defined and illustrated using the example of expenditures for contingency management. Ultimately, cost is one consideration in the overall determination of whether implementing an EBT is the best use of a program’s resources.
format Online
Article
Text
id pubmed-3120119
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher National Institute on Drug Abuse
record_format MEDLINE/PubMed
spelling pubmed-31201192011-06-22 Cost Evaluation of Evidence-Based Treatments Sindelar, Jody L. Ball, Samuel A. Addict Sci Clin Pract Clinical Perspective Many treatment programs have adopted or are considering adopting evidence-based treatments (EBTs). When a program evaluates whether to adopt a new intervention, it must consider program objectives, operational goals, and costs. This article examines cost concepts, cost estimation, and use of cost information to make the final decision on whether to adopt an EBT. Cost categories, including variable and fixed, accounting and opportunity, and costs borne by patients and others, are defined and illustrated using the example of expenditures for contingency management. Ultimately, cost is one consideration in the overall determination of whether implementing an EBT is the best use of a program’s resources. National Institute on Drug Abuse 2010-12 /pmc/articles/PMC3120119/ /pubmed/22002453 Text en
spellingShingle Clinical Perspective
Sindelar, Jody L.
Ball, Samuel A.
Cost Evaluation of Evidence-Based Treatments
title Cost Evaluation of Evidence-Based Treatments
title_full Cost Evaluation of Evidence-Based Treatments
title_fullStr Cost Evaluation of Evidence-Based Treatments
title_full_unstemmed Cost Evaluation of Evidence-Based Treatments
title_short Cost Evaluation of Evidence-Based Treatments
title_sort cost evaluation of evidence-based treatments
topic Clinical Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120119/
https://www.ncbi.nlm.nih.gov/pubmed/22002453
work_keys_str_mv AT sindelarjodyl costevaluationofevidencebasedtreatments
AT ballsamuela costevaluationofevidencebasedtreatments